{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T11:40:59Z","timestamp":1793101259758,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","award":["P30CA047904"],"award-info":[{"award-number":["P30CA047904"]}],"id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To examine associations between ductal carcinoma in situ (DCIS) patients\u2019 characteristics, treating locations and DCIS treatments received and to pilot assessing quality-of-life (QoL) values among DCIS patients with diverse backgrounds.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a retrospective tumor registry review of all patients diagnosed and treated with DCIS from 2018 to 2019 in the UPMC-integrated network throughout central and western Pennsylvania. Demographics, clinical information, and administered treatments were compiled from tumor registry records. We categorized contextual factors such as different hospital setting (academic vs. community), socioeconomic status based on the neighborhood deprivation index (NDI) as well as age and race. QoL survey was administered to DCIS patients with diverse backgrounds via QoL questionnaire breast cancer module 23 and qualitative assessment questions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 912 patients were reviewed. There were no treatment differences noted for age, race, or NDI. Mastectomy rate was higher in academic sites than community sites (29 vs. 20.4%; <jats:italic>p<\/jats:italic>\u2009=\u20090.0045), while hormone therapy (HT) utilization rate was higher in community sites (74 vs. 62%; <jats:italic>p<\/jats:italic>\u2009=\u20090.0012). QoL survey response rate was 32%. Only HT side effects negatively affected in QoL scores and there was no significant difference in QoL domains and decision-making process between races, age, NDI, treatment groups, and treatment locations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our integrated health network did not show chronically noted disparities arising from social determinates of health for DCIS treatments by implementing clinical pathways and system-wide peer review. Also, we demonstrated feasibility in collecting QoL for DCIS women with diverse backgrounds and different socioeconomic statuses.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10549-022-06831-w","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T04:27:56Z","timestamp":1671251276000},"page":"683-692","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Factors associated with ductal carcinoma in situ (DCIS) treatment patterns and patient-reported outcomes across a large integrated health network"],"prefix":"10.1007","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1301-0190","authenticated-orcid":false,"given":"Hayeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Demanelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Clump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Vargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Diego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Gorantla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret Q.","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,17]]},"reference":[{"key":"6831_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/jncimonographs\/lgq027","volume":"41","author":"K Kerlikowske","year":"2010","unstructured":"Kerlikowske K (2010) Epidemiology of ductal carcinoma in site. J Natl Cancer Inst Monogr 41:139\u2013141","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"8","key":"6831_CR2","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1001\/jama.2009.1211","volume":"302","author":"BL Sprague","year":"2009","unstructured":"Sprague BL, Trentham-Dietz A (2009) Prevalence of breast carcinoma in situ in the United States. JAMA 302(8):846\u2013848","journal-title":"JAMA"},{"issue":"4","key":"6831_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.1100","volume":"1","author":"V Giannakeas","year":"2018","unstructured":"Giannakeas V, Sopik V, Narod SA (2018) Association of radiotherapy with survival in women treated for ductalcarcinoma in situ with lumpectomy or mastectomy. JAMA Netw Open 1(4):e181100","journal-title":"JAMA Netw Open"},{"key":"6831_CR4","first-page":"162","volume":"41","author":"C Correa","year":"2010","unstructured":"Correa C, McGale P, Taylor C et al (2010) Early breast cancer trialists\u2019 collaborative group (EBCTCG). overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 41:162\u2013177","journal-title":"J Natl Cancer Inst Monogr"},{"key":"6831_CR5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/jnci\/djr027","volume":"103","author":"IL Wapnir","year":"2011","unstructured":"Wapnir IL, Dignam JJ, Fisher B et al (2011) Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 103:478\u2013488","journal-title":"J Natl Cancer Inst"},{"key":"6831_CR6","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1001\/jamainternmed.2013.8405","volume":"173","author":"ZB Omer","year":"2013","unstructured":"Omer ZB, Hwang ES, Esserman LJ et al (2013) Impact of ductal carcinoma in situ terminology on patient treatment preferences. JAMA Intern Med 173:1830\u20131831","journal-title":"JAMA Intern Med"},{"key":"6831_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3816\/CBC.2008.n.032","volume":"8","author":"A Partridge","year":"2008","unstructured":"Partridge A, Winer JP, Golshan M et al (2008) Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ. Clin Breast Cancer 8:275\u2013280","journal-title":"Clin Breast Cancer"},{"key":"6831_CR8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1634\/theoncologist.2012-0376","volume":"18","author":"KJ Ruddy","year":"2013","unstructured":"Ruddy KJ, Meyer ME, Giobbie-Hurder A et al (2013) Long-term risk perceptions of women with ductal carcinoma in situ. Oncologist 18:362\u2013368","journal-title":"Oncologist"},{"key":"6831_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ejca.2006.10.010","volume":"43","author":"YRBM van Gestel","year":"2007","unstructured":"van Gestel YRBM, Voogd AC, Vingerhoets AJJM et al (2007) A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ. Eur J Cancer 43:549\u2013556","journal-title":"Eur J Cancer"},{"key":"6831_CR10","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/tbj.13779","volume":"26","author":"EM Ozanne","year":"2020","unstructured":"Ozanne EM, Soeteman DI, Frank ES et al (2020) Commentary: creating a patient-centered decision aid for ductal carcinoma in situ. Breast J 26:1498\u20131499","journal-title":"Breast J"},{"issue":"4","key":"6831_CR11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1001\/jamaoncol.2021.7656","volume":"8","author":"G Sadigh","year":"2022","unstructured":"Sadigh G, Gray RJ, Sparono JA et al (2022) Assessment of racial disparity in survival outcomes for early hormone receptor-positive breast cancer after adjusting for insurance status and neighborhood deprivation a post hoc analysis of a randomized clinical trial. JAMA Oncol 8(4):579\u2013586","journal-title":"JAMA Oncol"},{"issue":"12","key":"6831_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.39593","volume":"4","author":"E Chang","year":"2021","unstructured":"Chang E, Soulos PR, Irwin ML et al (2021) Neighborhood and individual socioeconomic disadvantage and survival among patients with nonmetastatic common cancers. JAMA Netw Open 4(12):e2139593","journal-title":"JAMA Netw Open"},{"issue":"13","key":"6831_CR13","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1200\/JCO.21.02004","volume":"40","author":"RC Carlos","year":"2022","unstructured":"Carlos RC, Obeng-Gyasi S, Cole SW et al (2022) Linking Structural racism and discrimination and breast cancer outcomes: a social genomics approach. J Clin Oncol 40(13):1407\u20131413","journal-title":"J Clin Oncol"},{"issue":"7","key":"6831_CR14","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","volume":"1","author":"SA Narod","year":"2015","unstructured":"Narod SA, Iqbal J, Giannakeas V et al (2015) Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol 1(7):888\u2013896","journal-title":"JAMA Oncol"},{"key":"6831_CR15","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1001\/jama.2009.1450","volume":"302","author":"M Morrow","year":"2009","unstructured":"Morrow M, Jagsi R, Alderman AK, Griggs JJ, Hawley ST, Hamilton AS, Graff JJ, Katz SJ (2009) Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA 302:1551\u20131556","journal-title":"JAMA"},{"key":"6831_CR16","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/j.1525-1497.2006.00609.x","volume":"21","author":"MD Schleinitz","year":"2006","unstructured":"Schleinitz MD, Depalo D, Blume J et al (2006) Can differences in breast cancer utilities explain disparities in breast cancer care? J Gen Intern Med 21:1253\u20131260","journal-title":"J Gen Intern Med"},{"issue":"12","key":"6831_CR17","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1200\/JCO.2013.53.8009","volume":"32","author":"LM Ellis","year":"2014","unstructured":"Ellis LM et al (2014) American society of clinical oncology perspective: raising the bar for clinical trials by defining clinically meaningful outcomes. J Clin Oncol 32(12):1277\u20131280","journal-title":"J Clin Oncol"},{"key":"6831_CR18","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1001\/jama.2014.11100","volume":"312","author":"L Frank","year":"2014","unstructured":"Frank L, Basch E, Selby JV (2014) The PCORI perspective on patient-centered outcomes research. JAMA 312:1513\u20131514","journal-title":"JAMA"},{"key":"6831_CR19","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1200\/JCO.2016.67.8532","volume":"34","author":"AC Raldow","year":"2016","unstructured":"Raldow AC, Sher D, Chen AB et al (2016) Cost effectiveness of the oncotype DX DCIS score for guiding treatment of patients with ductal carcinoma in situ. J Clin Oncol 34:3963\u20133968","journal-title":"J Clin Oncol"},{"issue":"10","key":"6831_CR20","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1200\/JCO.1996.14.10.2756","volume":"14","author":"MA Sprangers","year":"1996","unstructured":"Sprangers MA, Groenvold M, Arraras JI et al (1996) The European organization for research and treatment of cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 14(10):2756\u20132768","journal-title":"J Clin Oncol"},{"key":"6831_CR21","doi-asserted-by":"publisher","unstructured":"Jayadevappa R, Chhatre S, Gallo JJ, et al. 2020 Helping Men With Prostate Cancer Determine Their Preferences for Treatment. Washington, DC: Patient-Centered Outcomes Research Institute (PCORI). https:\/\/doi.org\/10.25302\/04.2020.CE.12114973","DOI":"10.25302\/04.2020.CE.12114973"},{"key":"6831_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/jnci\/djp485","volume":"102","author":"CJ Allegra","year":"2009","unstructured":"Allegra CJ, Aberle DR, Ganschow P et al (2009) National institutes of health state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ. J Natl Cancer Inst 102:161\u2013169","journal-title":"J Natl Cancer Inst"},{"key":"6831_CR23","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1245\/s10434-014-3802-7","volume":"21","author":"CC Greenberg","year":"2014","unstructured":"Greenberg CC, Habel LA, Hughes ME et al (2014) Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ. Ann Surg Oncol 21:3766\u20133773","journal-title":"Ann Surg Oncol"},{"key":"6831_CR24","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1093\/jnci\/djt256","volume":"105","author":"RS Punglia","year":"2013","unstructured":"Punglia RS, Schnitt SJ, Weeks JC (2013) Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate? J Natl Cancer Inst 105:1527\u20131533","journal-title":"J Natl Cancer Inst"},{"key":"6831_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40064-014-0776-7","volume":"4","author":"HS Feigelson","year":"2015","unstructured":"Feigelson HS, Carroll NM, Weinmann S et al (2015) Treatment patterns for ductal carcinoma in situ from 2000\u20132010 across six integrated health plans. Springerplus 4:24","journal-title":"Springerplus"},{"issue":"3","key":"6831_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1200\/JCO.21.01674","volume":"40","author":"JL Wright","year":"2021","unstructured":"Wright JL, Rahbar H, Obeng-G S et al (2021) Overcoming barriers in DCIS management: from overtreatment to optimal treatment. J Clin Oncol 40(3):225\u2013230","journal-title":"J Clin Oncol"},{"issue":"18","key":"6831_CR27","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1002\/cncr.30105","volume":"122","author":"O Shiyanbola","year":"2016","unstructured":"Shiyanbola O, Sprague BL, Hampton JM et al (2016) Emerging trends in surgical and adjuvant radiation therapies among women diagnosed with ductal carcinoma in situ. Cancer 122(18):2810\u20132818","journal-title":"Cancer"},{"key":"6831_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv263","author":"M Worni","year":"2015","unstructured":"Worni M, Akushevich I, Greenup R et al (2015) Trends in treatment patterns and outcomes for ductal carcinoma in situ. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djv263","journal-title":"J Natl Cancer Inst"},{"key":"6831_CR29","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10549-017-4436-9","volume":"166","author":"Y Sagara","year":"2017","unstructured":"Sagara Y, Freedman RA, Wong SM et al (2017) Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004\u20132013. Breast Cancer Res Treat 166:583\u2013592","journal-title":"Breast Cancer Res Treat"},{"key":"6831_CR30","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1200\/JCO.21.01083","volume":"39","author":"B McCormick","year":"2021","unstructured":"McCormick B, Winter KA, Woodward W et al (2021) Randomized Phase III trial evaluating radiation following surgical excision for good risk DCIS: Long term report from NRG oncology\/RTOG 9804. J Clin Oncol 39:3574\u20133582","journal-title":"J Clin Oncol"},{"key":"6831_CR31","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1245\/s10434-021-09972-2","volume":"28","author":"DJ Byun","year":"2021","unstructured":"Byun DJ, Wu SP, Nagar H et al (2021) Ductal carcinoma in situ in young women: increasing rates of mastectomy and variability in endocrine therapy use. Ann Surg Oncol 28:6083\u20136096","journal-title":"Ann Surg Oncol"},{"key":"6831_CR32","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1245\/s10434-017-5930-3","volume":"24","author":"TT Nguyen","year":"2017","unstructured":"Nguyen TT, Hoskin TL, Day CN et al (2017) Factors influencing use of hormone therapy for ductal carcinoma in situ: a national cancer database study. Ann Surg Oncol 24:2989\u20132998","journal-title":"Ann Surg Oncol"},{"key":"6831_CR33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.breast.2016.09.001","volume":"31","author":"EJ Groen","year":"2017","unstructured":"Groen EJ, Elshof LE, Visser LL et al (2017) Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS). The Breast 31:274\u2013283","journal-title":"The Breast"},{"key":"6831_CR34","doi-asserted-by":"crossref","unstructured":"Levy J, Farag F, Cole, J. 2022 Factors influencing the initiation of adjuvant endocrine therapy in patients with estrogen receptor-positive ductal carcinoma in situ: a single institution experience. Breast Cancer Res Treat (Online ahead of print).","DOI":"10.21203\/rs.3.rs-1795603\/v1"},{"issue":"8","key":"6831_CR35","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.25485","volume":"5","author":"X Hu","year":"2022","unstructured":"Hu X, Walker MS, Stepanski E et al (2022) Racial differences in patient reported symptoms and adherence to adjuvant endocrine therapy among women with early stage, hormone receptor positive breast cancer. JAMA Netw Open 5(8):e2225485","journal-title":"JAMA Netw Open"},{"issue":"4","key":"6831_CR36","doi-asserted-by":"publisher","first-page":"pkz052","DOI":"10.1093\/jncics\/pkz052","volume":"3","author":"P Hung","year":"2019","unstructured":"Hung P, Wang SY, Killlelea BK et al (2019) Long term outcomes of sentinel lymph node biopsy for DCIS. JNCI Cancer Spectr 3(4):pkz052","journal-title":"JNCI Cancer Spectr"},{"key":"6831_CR37","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1245\/s10434-018-6410-0","volume":"25","author":"BK Killlelea","year":"2018","unstructured":"Killlelea BK, Long JB, Dang W et al (2018) Associations between sentinel lymph node biopsy and complications for patients with ductal carcinoma in situ. Ann Surg Oncol 25:1521\u20131529","journal-title":"Ann Surg Oncol"},{"key":"6831_CR38","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s12282-017-0765-0","volume":"24","author":"R Merciaca-Bebber","year":"2017","unstructured":"Merciaca-Bebber R, King MT, Boxer MM et al (2017) What quality of life issues do women with DCIS consider important when making treatment decisions? Breast Cancer 24:720\u2013729","journal-title":"Breast Cancer"},{"key":"6831_CR39","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1200\/JCO.2005.11.692","volume":"23","author":"JA Hayman","year":"2005","unstructured":"Hayman JA, Kabeto MU, Schipper MJ et al (2005) Assessing the benefit of radiation therapy after breast- conserving surgery for ductal carcinoma-in-situ. J Clin Oncol 23:5171\u20135177","journal-title":"J Clin Oncol"},{"key":"6831_CR40","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1200\/JCO.2015.62.7281","volume":"34","author":"V Hart","year":"2016","unstructured":"Hart V, Sprague BL, Lakoski SG et al (2016) Trends in health related quality of life after a diagnosis of DCIS. J Clin Oncol 34:1323\u20131329","journal-title":"J Clin Oncol"},{"key":"6831_CR41","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10549-019-05132-z","volume":"174","author":"AR Gagliardi","year":"2019","unstructured":"Gagliardi AR, Wright FC, Hong NJ et al (2019) National consensus recommendations on patient centered care for ductal carcinoma in situ. Breast Cancer Res Treat 174:561\u2013570","journal-title":"Breast Cancer Res Treat"},{"key":"6831_CR42","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1200\/JCO.21.00831","volume":"39","author":"A Gupta","year":"2021","unstructured":"Gupta A, Jhawar SR, Saya M et al (2021) Cost-effectiveness of adjuvant treatment for ductal carcinoma in situ. J Clin Oncol 39:2386\u20132396","journal-title":"J Clin Oncol"},{"issue":"3","key":"6831_CR43","doi-asserted-by":"publisher","first-page":"e026797","DOI":"10.1136\/bmjopen-2018-026797","volume":"9","author":"ES Hwang","year":"2019","unstructured":"Hwang ES, Hyslop T, Lynch T et al (2019) The COMET (comparison of operative versus monitoring and endocrine therapy) trial: a Phase III randomized clinical trial for low-risk DCIS. BMJ Open 9(3):e026797","journal-title":"BMJ Open"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06831-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-022-06831-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06831-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T05:33:41Z","timestamp":1674797621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-022-06831-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,17]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["6831"],"URL":"https:\/\/doi.org\/10.1007\/s10549-022-06831-w","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,17]]},"assertion":[{"value":"28 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}